Weeks 12: 2 mg once weekly Weeks 34: 4 mg once weekly Weeks 58: 8 mg once weekly Week 9+: 12 mg once weekly Efficacy and safety: The reason for the slow and gradual dosing protocol The Phase 2 clinical trial of retatrutide demonstrated that participants receiving the highest dose (12 mg) achieved up to 24% weight reduction after 48 weeks
Signal 28 , 643661 (2018)
To minimize this risk, your healthcare provider may adjust your insulin dosage
It acts as a vital antioxidant in the body, helping to neutralize free radicals and support detoxification
ARC GABAergic neurons that express thyrotropin-releasing hormone (TRH), approximately 60% of which expressed GLP-1R, were found to have GABAergic afferents directly targeting AgRP neurons
Its effectiveness varies with individual health, lifestyle, and concurrent therapies